BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoffmann-Vold AM, Distler O, Murray B, Kowal-Bielecka O, Khanna D, Allanore Y; EUSTAR and SCTC collaborators. Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features. RMD Open 2019;5:e000826. [PMID: 30997150 DOI: 10.1136/rmdopen-2018-000826] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Giucă A, Gegenava T, Mihai CM, Jurcuţ C, Săftoiu A, Gȋrniţă DM, Popescu BA, Ajmone Marsan N, Jurcuț R. Sclerodermic Cardiomyopathy—A State-of-the-Art Review. Diagnostics 2022;12:669. [DOI: 10.3390/diagnostics12030669] [Reference Citation Analysis]
2 Khanna D, Distler O, Cottin V, Brown KK, Chung L, Goldin JG, Matteson EL, Kazerooni EA, Walsh SL, Mcnitt-gray M, Maher TM. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. Journal of Scleroderma and Related Disorders. [DOI: 10.1177/23971983211064463] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Herrick AL. Raynaud's phenomenon and digital ulcers: advances in evaluation and management. Curr Opin Rheumatol 2021;33:453-62. [PMID: 34420003 DOI: 10.1097/BOR.0000000000000826] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Bruni C, Buch MH, Furst DE, De Luca G, Djokovic A, Dumitru RB, Giollo A, Polovina M, Steelandt A, Bratis K, Suliman YA, Milinkovic I, Baritussio A, Hasan G, Xintarakou A, Isomura Y, Markousis-mavrogenis G, Tofani L, Mavrogeni S, Gargani L, Caforio AL, Tschöpe C, Ristic A, Klingel K, Plein S, Behr ER, Allanore Y, Kuwana M, Denton CP, Khanna D, Krieg T, Marcolongo R, Galetti I, Zanatta E, Tona F, Seferovic P, Matucci-cerinic M. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition. Journal of Scleroderma and Related Disorders 2022;7:24-32. [DOI: 10.1177/23971983211053246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ross L, Paratz E, Baron M, La Gerche A, Nikpour M. Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management. Diagnostics (Basel) 2021;11:1781. [PMID: 34679479 DOI: 10.3390/diagnostics11101781] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Buschulte K, Hoffmann-Vold AM, Dobrota RD, Höger P, Krause A, Kreuter M. [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)]. Z Rheumatol 2021;80:743-54. [PMID: 34505934 DOI: 10.1007/s00393-021-01067-3] [Reference Citation Analysis]
7 van Leeuwen NM, Maurits M, Liem S, Ciaffi J, Ajmone Marsan N, Ninaber M, Allaart C, Gillet van Dongen H, Goekoop R, Huizinga T, Knevel R, De Vries-Bouwstra J. New risk model is able to identify patients with a low risk of progression in systemic sclerosis. RMD Open 2021;7:e001524. [PMID: 34059523 DOI: 10.1136/rmdopen-2020-001524] [Reference Citation Analysis]
8 Hoffmann-Vold AM, Molberg Ø. Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis. Curr Opin Rheumatol 2020;32:497-504. [PMID: 32890027 DOI: 10.1097/BOR.0000000000000741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Bruni C, Ross L. Cardiac involvement in systemic sclerosis: Getting to the heart of the matter. Best Pract Res Clin Rheumatol 2021;35:101668. [PMID: 33736950 DOI: 10.1016/j.berh.2021.101668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O. Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review. ERJ Open Res 2021;7:00235-2020. [PMID: 33644224 DOI: 10.1183/23120541.00235-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt Ø, Molberg Ø, Hoffmann-Vold AM. Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort. Rheumatology (Oxford) 2020;59:2920-9. [PMID: 32097470 DOI: 10.1093/rheumatology/keaa026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
12 Benvenuti F, Zanatta E, Avouac J, Müller-ladner U, Cozzi F, Hoffmann-vold A, Gabrielli A, Distler O, Matucci-cerinic M, Allanore Y, Doria A. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Expert Review of Clinical Immunology 2020;16:1065-74. [DOI: 10.1080/1744666x.2021.1836962] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Chrabaszcz M, Małyszko J, Sikora M, Alda-Malicka R, Stochmal A, Matuszkiewicz-Rowinska J, Rudnicka L. Renal Involvement in Systemic Sclerosis: An Update. Kidney Blood Press Res 2020;45:532-48. [PMID: 32521536 DOI: 10.1159/000507886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
14 Hoffmann-vold A, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, Carducci P, Carreira PE, Castellví I, Del Galdo F, Distler JHW, Foeldvari I, Fraticelli P, George PM, Griffiths B, Guillén-del-castillo A, Hamid AM, Horváth R, Hughes M, Kreuter M, Moazedi-fuerst F, Olas J, Paul S, Rotondo C, Rubio-rivas M, Seferian A, Tomčík M, Uzunhan Y, Walker UA, Więsik-szewczyk E, Distler O. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. The Lancet Rheumatology 2020;2:e71-83. [DOI: 10.1016/s2665-9913(19)30144-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 29.5] [Reference Citation Analysis]
15 Hoffmann-vold A, Fretheim H, Meier C, Maurer B. Circulating biomarkers of systemic sclerosis – interstitial lung disease. Journal of Scleroderma and Related Disorders 2020;5:41-7. [DOI: 10.1177/2397198319894851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Schinke S, Riemekasten G. [Systemic sclerosis]. Internist (Berl) 2019;60:1251-69. [PMID: 31754753 DOI: 10.1007/s00108-019-00699-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]